Next Article in Journal
Reduction-Responsive Molecularly Imprinted Poly(2-isopropenyl-2-oxazoline) for Controlled Release of Anticancer Agents
Next Article in Special Issue
Development of Antibody–Oligonucleotide Complexes for Targeting Exosomal MicroRNA
Previous Article in Journal
Particle-Size-Dependent Delivery of Antitumoral miRNA Using Targeted Mesoporous Silica Nanoparticles
 
 
Article

Article Versions Notes

Pharmaceutics 2020, 12(6), 507; https://doi.org/10.3390/pharmaceutics12060507
Action Date Notes Link
article pdf uploaded. 2 June 2020 12:58 CEST Version of Record https://www.mdpi.com/1999-4923/12/6/507/pdf-vor
article xml file uploaded 28 June 2020 03:15 CEST Original file -
article xml uploaded. 28 June 2020 03:15 CEST Update -
article pdf uploaded. 28 June 2020 03:15 CEST Updated version of record https://www.mdpi.com/1999-4923/12/6/507/pdf-vor
article html file updated 28 June 2020 03:16 CEST Original file -
article xml file uploaded 29 June 2020 12:55 CEST Update -
article xml uploaded. 29 June 2020 12:55 CEST Update https://www.mdpi.com/1999-4923/12/6/507/xml
article pdf uploaded. 29 June 2020 12:55 CEST Updated version of record https://www.mdpi.com/1999-4923/12/6/507/pdf
article html file updated 29 June 2020 12:56 CEST Update -
article html file updated 21 July 2022 06:47 CEST Update https://www.mdpi.com/1999-4923/12/6/507/html
Back to TopTop